Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.09%162.1M | -35.50%158.78M | -50.99%23.79M | -49.10%34.38M | -38.56%38.11M | -8.14%62.5M | -32.62%246.16M | -40.56%48.54M | -22.90%67.54M | -32.97%62.04M |
| Cost of revenue | -1.93%33.74M | 34.4M | 1.92M | |||||||
| Gross profit | 3.20%128.36M | 124.38M | 21.87M | |||||||
| Operating expense | -24.58%702.41M | 55.10%931.38M | 0.12%211.99M | 66.96%216.29M | 132.73%292.5M | 57.70%210.6M | -15.57%600.51M | 10.01%211.74M | -26.09%129.55M | -25.65%125.68M |
| Staff costs | -16.21%454.44M | 204.03%542.34M | ---- | ---- | ---- | ---- | -20.36%178.38M | ---- | ---- | ---- |
| Selling and administrative expenses | ---- | -27.43%162.54M | ---- | ---- | ---- | ---- | 7.50%223.97M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | -33.12%66.27M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 3.07%162.54M | ---- | ---- | ---- | ---- | 44.36%157.7M | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | -97.20%3.8M | ---- | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | -97.20%3.8M | ---- | ---- | ---- |
| Other operating expenses | -36.26%247.97M | 100.17%389.04M | ---- | ---- | ---- | ---- | 35.52%194.36M | ---- | ---- | ---- |
| Operating profit | 28.87%-574.04M | -127.75%-807M | -16.50%-190.13M | -245.78%-214.4M | -299.71%-254.39M | -126.10%-148.09M | -2.45%-354.34M | -47.28%-163.2M | 29.28%-62M | 16.78%-63.64M |
| Net non-operating interest income (expenses) | 109.95%4.73M | -47.59M | -54.61M | 7,323.26%3.19M | 2.72M | 2,676.74%1.11M | 0 | 0 | 43K | 0 |
| Non-operating interest income | -1.21%12.63M | --12.78M | --5.7M | --3.22M | --2.74M | --1.14M | --0 | --0 | --0 | --0 |
| Non-operating interest expense | 0.00%103K | --103K | --32K | --23K | --21K | -37.21%27K | ---- | ---- | ---- | --0 |
| Total other finance cost | -87.07%7.79M | --60.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -93K | -608.54%-417K | 358.00%229K | 774.63%586K | 53.02%456K | 414.00%257K | 70.83%82K | -43.82%50K | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -508.41%-212.29M | 52.06%-34.89M | -32.04M | 0 | -45K | -2.81M | -72.78M | 0 | ||
| Less:Other special charges | 169.56%94.06M | -46.21%34.89M | --32.04M | --0 | --45K | --2.81M | --64.87M | ---- | ---- | ---- |
| Less:Write off | --118.23M | --0 | ---- | ---- | ---- | ---- | --7.91M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 171.30%3.16M | 46.34%-4.43M | 720.85%53.54M | 2,721.92%2.06M | -48,589.52%-60.13M | -44.44%100K | -1,562.70%-8.25M | -2,128.42%-8.62M | 108.53%73K | 217.95%124K |
| Income before tax | 12.91%-778.54M | -105.54%-893.91M | 8.48%-223.63M | -239.07%-209.56M | -390.97%-311.62M | -128.37%-149.11M | -26.28%-434.92M | -119.84%-244.35M | 30.15%-61.81M | 16.11%-63.47M |
| Income tax | 20.81%1.28M | 11.91%1.06M | 47.68%350K | 0.00%237K | 0.00%238K | 0.00%237K | -0.11%949K | -0.42%237K | 0.00%237K | 0.00%238K |
| Net income | 12.87%-779.82M | -105.33%-894.97M | 8.43%-223.98M | -238.15%-209.8M | -389.51%-311.85M | -127.90%-149.35M | -26.21%-435.87M | -119.59%-244.59M | 30.07%-62.04M | 16.06%-63.71M |
| Net income continuous operations | 12.87%-779.82M | -105.33%-894.97M | 8.43%-223.98M | -238.16%-209.8M | -389.51%-311.85M | -127.90%-149.34M | -26.21%-435.87M | -119.59%-244.59M | 30.07%-62.04M | 16.06%-63.71M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 12.87%-779.82M | -105.33%-894.97M | 8.43%-223.98M | -238.15%-209.8M | -389.51%-311.85M | -127.90%-149.35M | -26.21%-435.87M | -119.59%-244.59M | 30.07%-62.04M | 16.06%-63.71M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 12.87%-779.82M | -105.33%-894.97M | 8.43%-223.98M | -238.15%-209.8M | -389.51%-311.85M | -127.90%-149.35M | -26.21%-435.87M | -119.59%-244.59M | 30.07%-62.04M | 16.06%-63.71M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 21.55%-39.27 | -61.43%-50.06 | 32.44%-11.64 | -193.51%-13.12 | -255.35%-16.3104 | -110.59%-9.94 | -24.64%-31.01 | -114.84%-17.23 | 30.16%-4.47 | 15.93%-4.59 |
| Diluted earnings per share | 21.55%-39.27 | -61.43%-50.06 | 32.01%-11.7144 | -193.51%-13.12 | -255.35%-16.3104 | -110.59%-9.94 | -24.64%-31.01 | -114.70%-17.23 | 30.16%-4.47 | 16.06%-4.59 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |